Sex modifies theAPOE-related risk of developing Alzheimer disease

GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease

(2013) Carlos Cruchaga et al.   NEURON

The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: Findings from a nationally representative study.

(2013) C. J. Brainerd et al.   NEUROPSYCHOLOGY

Relationship between genetic risk factors and markers for Alzheimer’s disease pathology

(2012) Lyzel S Elias-Sonnenschein et al.   Biomarkers in Medicine

Gender Modulates the APOE  4 Effect in Healthy Older Adults: Convergent Evidence from Functional Brain Connectivity and Spinal Fluid Tau Levels

(2012) J. S. Damoiseaux et al.   JOURNAL OF NEUROSCIENCE

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Prevalence of Apolipoprotein E4 Genotype and Homozygotes (APOE e4/4) among Patients Diagnosed with Alzheimer’s Disease: A Systematic Review and Meta-Analysis

(2011) Alex Ward et al.   NEUROEPIDEMIOLOGY

Testing the Right Target and Right Drug at the Right Stage

(2011) R. A. Sperling et al.   Science Translational Medicine

The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans

(2010) Michael W. Weiner et al.   Alzheimers & Dementia

Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline

(2010) May A. Beydoun et al.   NEUROBIOLOGY OF AGING

Aβ-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease

(2010) Yadong Huang   TRENDS IN MOLECULAR MEDICINE

Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?

(2010) Martin R Farlow   Alzheimers Research & Therapy

The Alzheimerʼs Disease Centersʼ Uniform Data Set (UDS)

(2009) Sandra Weintraub et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Comments on ‘Choice of time scale and its effect on significance of predictors in longitudinal studies’ by Michael J. Pencina, Martin G. Larson and Ralph B. D'Agostino,Statistics in Medicine2007;26:1343-1359

(2009) Mitchell H. Gail et al.   STATISTICS IN MEDICINE